KyungDong Pharm home

Consolidated Statement of Financial Position (unit: won)

statement of financial position
item202520242023
current assets112,757,577,818101,829,283,95789,748,780,615
non-current assets209,137,890,306201,043,341,666203,221,984,570
Total assets321,895,468,124302,872,625,623292,970,765,185
current liabilities69,585,211,15678,428,372,66759,027,091,132
Non-current liabilities23,437,153,5234,107,296,2945,466,631,932
Total debt93,022,364,67982,535,668,96164,493,723,064
capital15,684,383,00015,684,383,00015,684,383,000
capital surplus35,525,015,26234,100,089,96934,108,284,559
Other capital items-24,054,025,441-30,296,776,552-29,080,294,586
Accumulated other comprehensive income7,587,550,2317,273,682,6878,850,369,760
retained earnings193,614,537,030193,299,376,887198,616,236,105
Non-controlling interest515,643,363276,200,671298,063,283
Total capital228,873,103,445220,336,956,662228,477,042,121

Consolidated Income Statement (unit: won)

Consolidated Income Statement
item202520242023
sales196,273,042,787193,936,297,352162,674,098,953
Cost of sales79,117,439,22979,534,271,68673,261,360,202
gross profit117,155,603,558114,402,025,66689,412,738,751
Technology development cost6,037,408,7898,652,183,21710,778,881,532
Selling and administrative expenses103,452,037,794103,126,237,472103,588,413,925
operating profit7,666,156,9752,623,604,977-24,954,556,706
Net profit before corporate tax expenses9,122,813,0355,221,072,176-18,503,488,246
corporate tax cost672,048,805-226,717,1142,226,835,306
net profit8,450,764,2305,447,789,290-20,730,323,552